Triple
T7392989
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | George Church |
E170546
|
entity |
| Predicate | coFounded |
P104
|
FINISHED |
| Object |
Dyno Therapeutics
Dyno Therapeutics is a biotechnology company that uses artificial intelligence and machine learning to design optimized adeno-associated virus (AAV) gene therapy vectors.
|
E661993
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Dyno Therapeutics | Statement: [George Church, coFounded, Dyno Therapeutics]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Dyno Therapeutics Context triple: [George Church, coFounded, Dyno Therapeutics]
-
A.
Insitro
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
-
B.
Nautilus Biotechnology
Nautilus Biotechnology is a life sciences company developing next-generation, high-throughput proteomics platforms to enable comprehensive analysis of the human proteome for research and drug discovery.
-
C.
Ridgeback Biotherapeutics
Ridgeback Biotherapeutics is a biotechnology company focused on developing antiviral and immunotherapy treatments for serious infectious diseases, including Ebola and COVID-19.
-
D.
Juno Therapeutics
Juno Therapeutics is a biotechnology company focused on developing cutting-edge immunotherapies, particularly CAR-T cell treatments, for cancer.
-
E.
Array BioPharma
Array BioPharma is a biopharmaceutical company known for developing targeted small-molecule cancer therapies, particularly in oncology and rare diseases.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Dyno Therapeutics Triple: [George Church, coFounded, Dyno Therapeutics]
Generated description
Dyno Therapeutics is a biotechnology company that uses artificial intelligence and machine learning to design optimized adeno-associated virus (AAV) gene therapy vectors.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Dyno Therapeutics Target entity description: Dyno Therapeutics is a biotechnology company that uses artificial intelligence and machine learning to design optimized adeno-associated virus (AAV) gene therapy vectors.
-
A.
Insitro
Insitro is a biotechnology company that uses machine learning and high-throughput biology to accelerate drug discovery and development.
-
B.
Nautilus Biotechnology
Nautilus Biotechnology is a life sciences company developing next-generation, high-throughput proteomics platforms to enable comprehensive analysis of the human proteome for research and drug discovery.
-
C.
Ridgeback Biotherapeutics
Ridgeback Biotherapeutics is a biotechnology company focused on developing antiviral and immunotherapy treatments for serious infectious diseases, including Ebola and COVID-19.
-
D.
Juno Therapeutics
Juno Therapeutics is a biotechnology company focused on developing cutting-edge immunotherapies, particularly CAR-T cell treatments, for cancer.
-
E.
Array BioPharma
Array BioPharma is a biopharmaceutical company known for developing targeted small-molecule cancer therapies, particularly in oncology and rare diseases.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c68a5e2c9081909e713ce866e0060a |
completed | March 27, 2026, 1:47 p.m. |
| NER | Named-entity recognition | batch_69c6f224790c819099ceb7c7ac8d00f6 |
completed | March 27, 2026, 9:09 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69c810f82ba08190919924b0994a2eee |
completed | March 28, 2026, 5:33 p.m. |
| NEDg | Description generation | batch_69c811f1fe3c8190a591186b19044b5f |
completed | March 28, 2026, 5:37 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69c812c1e9d08190b0e7f052d87011b9 |
completed | March 28, 2026, 5:41 p.m. |
Created at: March 27, 2026, 3:09 p.m.